These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 9063674)

  • 1. Trends in immunotherapy of fungal infections.
    Kullberg BJ
    Eur J Clin Microbiol Infect Dis; 1997 Jan; 16(1):51-5. PubMed ID: 9063674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokines in the treatment of fungal infections.
    Kullberg BJ; van 't Wout JW
    Biotherapy; 1994; 7(3-4):195-210. PubMed ID: 7865351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of immunoreconstitution in the management of refractory opportunistic fungal infections.
    Roilides E; Dignani MC; Anaissie EJ; Rex JH
    Med Mycol; 1998; 36 Suppl 1():12-25. PubMed ID: 9988488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of efficacy trials of cytokines in combination with antifungal drugs.
    Kullberg BJ; Oude Lashof AM; Netea MG
    Clin Infect Dis; 2004 Oct; 39 Suppl 4():S218-23. PubMed ID: 15546121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plant production of anti-β-glucan antibodies for immunotherapy of fungal infections in humans.
    Capodicasa C; Chiani P; Bromuro C; De Bernardis F; Catellani M; Palma AS; Liu Y; Feizi T; Cassone A; Benvenuto E; Torosantucci A
    Plant Biotechnol J; 2011 Sep; 9(7):776-87. PubMed ID: 21265996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hematopoietic growth factors in cancer patients with invasive fungal infections.
    Offner F
    Eur J Clin Microbiol Infect Dis; 1997 Jan; 16(1):56-63. PubMed ID: 9063675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokines in immunodeficient patients with invasive fungal infections: an emerging therapy.
    Roilides E; Lamaignere CG; Farmaki E
    Int J Infect Dis; 2002 Sep; 6(3):154-63. PubMed ID: 12718828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy in patients with systemic mycoses: a promising adjunct.
    Farmaki E; Roilides E
    BioDrugs; 2001; 15(4):207-14. PubMed ID: 11437686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy for fungal infections.
    Segal BH; Kwon-Chung J; Walsh TJ; Klein BS; Battiwalla M; Almyroudis NG; Holland SM; Romani L
    Clin Infect Dis; 2006 Feb; 42(4):507-15. PubMed ID: 16421795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy against invasive fungal diseases in stem cell transplant recipients.
    Lehrnbecher T; Tramsen L; Koehl U; Schmidt S; Bochennek K; Klingebiel T
    Immunol Invest; 2011; 40(7-8):839-52. PubMed ID: 21627412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overview of host defense mechanisms in systemic mycoses and the basis for immunotherapy.
    Clemons KV; Stevens DA
    Semin Respir Infect; 2001 Mar; 16(1):60-6. PubMed ID: 11309713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunomodulation with interferon-gamma and colony-stimulating factors for refractory fungal infections in patients with leukemia.
    Dignani MC; Rex JH; Chan KW; Dow G; deMagalhaes-Silverman M; Maddox A; Walsh T; Anaissie E
    Cancer; 2005 Jul; 104(1):199-204. PubMed ID: 15929126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Systemic fungal infections in immunocompromised patients].
    Zupanić-Krmek D; Nemet D
    Acta Med Croatica; 2004; 58(4):251-61. PubMed ID: 15700680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of fungal and other opportunistic infections in immunocompromised patients.
    Wade JC
    Leukemia; 1997 May; 11 Suppl 4():S38-9. PubMed ID: 9179282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapy of infections caused by rare filamentous fungi.
    Katragkou A; Roilides E
    Clin Microbiol Infect; 2012 Feb; 18(2):134-9. PubMed ID: 22044625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and therapy of fungal infection in patients with leukemia--new drugs and immunotherapy.
    Anaissie EJ
    Best Pract Res Clin Haematol; 2008 Dec; 21(4):683-90. PubMed ID: 19041608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of mycoses in surgical patients -- review of the literature.
    Holzheimer RG; Dralle H
    Eur J Med Res; 2002 May; 7(5):200-26. PubMed ID: 12069912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifungal immunity and adjuvant cytokine immune enhancement in cancer patients with invasive fungal infections.
    Safdar A
    Clin Microbiol Infect; 2007 Jan; 13(1):1-4. PubMed ID: 17184281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Spanish Paediatric Infectious Diseases Society consensus document on the treatment of fungal infections based on the immune response].
    Martín A; Soler-Palacín P; Español T; Dapena JL; Urrutia E; Navarro M; Alvez F; Figueras C;
    An Pediatr (Barc); 2010 Dec; 73(6):362.e1-8. PubMed ID: 20638349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy in invasive fungal infection--focus on invasive aspergillosis.
    Lehrnbecher T; Kalkum M; Champer J; Tramsen L; Schmidt S; Klingebiel T
    Curr Pharm Des; 2013; 19(20):3689-712. PubMed ID: 23278541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.